Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis.
Anahita Bassir NiaClaire L GibsonSharron A SpriggsSamantha E JankowskiDaniel DeFranciscoAmy SwiftCharles PerkelIgor GalynkerChandrashekhar HonraoAlexandros MakriyannisYasmin L HurdPublished in: Journal of psychopharmacology (Oxford, England) (2023)
Cannabis use is associated with low plasma AEA levels in individuals with psychosis, which is in the same line with reported suppressive effects of cannabis on the endocannabinoid system in healthy individuals. Further studies are needed to investigate the clinical significance of this finding.
Keyphrases